We're opening soonWe're opening soon. Sign up and get notified the moment we go live.
Get notified when we launch
10% off the entire range with codeLAUNCH10
Ordered before 16:00 = shipped the same day · 1-2 business days delivery within the Netherlands · Discreet shipping · Free shipping from €75 (NL/BE) / €150 (EU)
Research guide

MT-2 (Melanotan II)

MT-2 (Melanotan II) is a synthetic, non-selective melanocortin agonist analogous to α-MSH. In preclinical research it is studied in relation to pigmentation and central melanocortin signalling.

Shipped from the Netherlands≥ 99% purity

What is MT-2 (Melanotan II)?

MT-2 (Melanotan II) is a synthetic, non-selective melanocortin agonist analogous to α-MSH. In preclinical research it is studied in relation to pigmentation and central melanocortin signalling. This page is intended solely as an informational research guide for laboratory applications (Research Use Only).

Mechanism (preclinical)

Binds multiple melanocortin receptors (MC1R–MC5R) in in-vitro models.

Research areas

  • Melanogenesis and pigmentation
  • Appetite and satiety mechanisms (preclinical)
  • Sexual function in preclinical models
  • Melanocortin receptor research

Specifications

CAS
121062-08-6
Molecular formula
C50H69N15O9
Molecular weight
1024,18 g/mol
Purity
≥ 99%
Form
Lyophilised powder
Included
3 ml bacteriostatic water

Storage and reconstitution

Dry (lyophilised) powder can be stored long-term at -20 to -80 °C in an airtight, opaque container. After reconstitution with bacteriostatic water the solution must be refrigerated at 2 to 8 °C and protected from light.

Order MT-2 (Melanotan II) from Europa Peptides

Europa Peptides supplies MT-2 (Melanotan II) as lyophilised powder with ≥ 99% purity - 3 ml bacteriostatic water included. Shipped from our Netherlands warehouse. Orders placed before 16:00 on a business day ship the same day. For laboratory research only (RUO).

Important (RUO): This product is intended solely for in-vitro/in-vivo laboratory research by qualified scientific personnel. All information above describes associations from peer-reviewed preclinical literature and does not constitute a recommendation for any other application.